X BODY

Biotechnology, Developer Platform, Therapeutics
Founded in 2008-01-01
Waltham, Massachusetts, United States
For Profit

About X BODY

X-BODY is a biotechnology company that discovers and develops compounds against targets in oncology and ophthalmology. The company's mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate antibody therapeutic candidates. X-BODY's internal efforts are focused on discovering and developing compounds against biologically relevant targets in oncology and ophthalmology. X-BODY was formed in 2008 by industry veterans Richard Wagner, Brant Binder, and Gordon Binder.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 2 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 6802465 USD
  • Last Funding: 2662465 USD (Venture - Series Unknown)
  • Funding Status: M&A

Technology Stack

X BODY actively uses 2 products in their tech stack.

Market Presence

Industries: Biotechnology, Developer Platform, Therapeutics

Headquarters: Waltham, Massachusetts, United States